thymidine has been researched along with Rhabdomyolysis in 5 studies
Rhabdomyolysis: Necrosis or disintegration of skeletal muscle often followed by myoglobinuria.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Telbivudine can cause severe side effects, including myositis, neuritis, rhabdomyolysis, and lactic acidosis." | 8.95 | Rhabdomyolysis, lactic acidosis, and multiple organ failure during telbivudine treatment for hepatitis B: a case report and review of the literature. ( Chen, Z; Deng, M; Deng, Q; Deng, X; Li, D; Qiu, X; Yu, Z; Zheng, J, 2017) |
| "9% of patients on telbivudine treatment were reported to develop severe elevation of serum creatine phosphokinase (CPK) levels, but related clinical disease, like lactic acidosis (LA) and rhabdomyolysis (RM) were rare." | 7.88 | Case report: lactic acidosis and rhabdomyolysis during telbivudine and tenofovir treatment for chronic hepatitis B. ( Hu, YK; Huang, YX; Jin, JL; Ying, Y; Zhang, JM; Zhang, WH, 2018) |
| "Telbivudine can cause severe side effects, including myositis, neuritis, rhabdomyolysis, and lactic acidosis." | 4.95 | Rhabdomyolysis, lactic acidosis, and multiple organ failure during telbivudine treatment for hepatitis B: a case report and review of the literature. ( Chen, Z; Deng, M; Deng, Q; Deng, X; Li, D; Qiu, X; Yu, Z; Zheng, J, 2017) |
| "9% of patients on telbivudine treatment were reported to develop severe elevation of serum creatine phosphokinase (CPK) levels, but related clinical disease, like lactic acidosis (LA) and rhabdomyolysis (RM) were rare." | 3.88 | Case report: lactic acidosis and rhabdomyolysis during telbivudine and tenofovir treatment for chronic hepatitis B. ( Hu, YK; Huang, YX; Jin, JL; Ying, Y; Zhang, JM; Zhang, WH, 2018) |
| "Telbivudine (beta-l-2'-deoxythymidine) is an orally administered nucleoside analog drug approved for the treatment of patients with chronic hepatitis B since 2006." | 3.77 | Rhabdomyolysis in a 48-year-old man with hepatitis B-induced cirrhosis. ( Dang, S; Gao, N; Jia, X; Zhang, X, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mancebo González, A | 1 |
| Peñalver Jara, MJ | 1 |
| Menéndez Naranjo, L | 1 |
| Navarro Egea, AP | 1 |
| Zheng, J | 1 |
| Deng, M | 1 |
| Qiu, X | 1 |
| Chen, Z | 1 |
| Li, D | 1 |
| Deng, X | 1 |
| Deng, Q | 1 |
| Yu, Z | 1 |
| Ying, Y | 1 |
| Hu, YK | 1 |
| Jin, JL | 1 |
| Zhang, JM | 1 |
| Zhang, WH | 1 |
| Huang, YX | 1 |
| Dang, S | 1 |
| Gao, N | 1 |
| Zhang, X | 1 |
| Jia, X | 1 |
1 review available for thymidine and Rhabdomyolysis
| Article | Year |
|---|---|
Rhabdomyolysis, lactic acidosis, and multiple organ failure during telbivudine treatment for hepatitis B: a case report and review of the literature.
Topics: Acidosis, Lactic; Adult; Antiviral Agents; Asian People; Hepatitis B, Chronic; Humans; Male; Multipl | 2017 |
4 other studies available for thymidine and Rhabdomyolysis
| Article | Year |
|---|---|
[Rhabdomyolysis associated with telbivudin therapy: report of a case].
Topics: Adult; Antiviral Agents; Humans; Male; Rhabdomyolysis; Telbivudine; Thymidine | 2017 |
Case report: lactic acidosis and rhabdomyolysis during telbivudine and tenofovir treatment for chronic hepatitis B.
Topics: Acidosis, Lactic; Antiviral Agents; DNA Polymerase gamma; Drug Therapy, Combination; Hepatitis B, Ch | 2018 |
Telbivudine: rhabdomyolysis and neuropathy.
Topics: Antiviral Agents; Hepatitis B, Chronic; Humans; Nucleosides; Peripheral Nervous System Diseases; Pyr | 2010 |
Rhabdomyolysis in a 48-year-old man with hepatitis B-induced cirrhosis.
Topics: Acute Kidney Injury; Antiviral Agents; Fatal Outcome; Fibrosis; Hepatitis B; Humans; Male; Middle Ag | 2011 |